Investors need to be patient in this sector as it's only just kicking off, CGB has their fingers on the pulse making small revenue on food products and I assume processing other companies products through HHC. Once Canntab and Pharmocann becomes revenue and then profits, well then sky's the limited. More research other products Cann Global Limited becomes a class act. AIMO DYOR. Only Time Will Tell.
CGB Price at posting:
3.7¢ Sentiment: Buy Disclosure: Held
